Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Gilead Sciences Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 19
» View wsbtradio.com items only
    May 17, 2013 |Story| Reuters

  1. U.S. RESEARCH ROUNDUP: Visa, Wal-Mart, Biogen Idec, Walt Disney

    Reuters
    May 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Macy's and Biogen Idec on Friday. HIGHLIGHTS * Aruba Networks : FBN, JP Morgan, Needham, Wedbush, Wells Fargo cut rating *...

    Tags: Marketing, Beazer Homes USA Incorporated, Triumph Group Inc., AT&T Corp., Weight

    2. May 15, 2013 |Story| Reuters

  2. Experimental Gilead drug effective in early-stage leukemia trial

    Reuters
    By Deena Beasley May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest...

    Tags: Lymphoma, Medical Specialization, National Hockey League, Medical Research, Health Treatments

    3. May 13, 2013 |Story| Reuters

  3. U.S. RESEARCH ROUNDUP: AIG, Express Scripts, Eli Lilly, Carlyle Group

    Reuters
    May 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including AIG, Carlyle Group and Express Scripts, on Monday. HIGHLIGHTS * AIG : Barclays raises to overweight from equal weight -...

    Tags: Marketing, Highwoods Properties Inc., True Religion Apparel Inc., Sequenom Incorporated, Kennametal Incorporated

    4. May 8, 2013 |Story| Reuters

  4. Many in U.S. don't get proper testing for hepatitis C- CDC

    Reuters
    By Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...

    Tags: Viral Diseases and Infections, Medical Research, Cirrhosis, Medical Procedures and Tests, Drugs and Medicines

    5. May 7, 2013 |Story| Reuters

  5. REUTERS SUMMIT-Biotech firms evolve from targets to acquirers

    Reuters
    (For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Skyrocketing valuations quash talks * With financing available, many biotechs go it alone * Bankers expect steady flow of $1 bln to $5 bln pharma deals By...

    Tags: Mergers, Acquisitions and Takeovers, Macular Degeneration, Biotechnology, Hepatitis C , Celgene Corporation

    6. May 3, 2013 |Story| Reuters

  6. U.S. RESEARCH ROUNDUP: Estee Lauder, Actavis, MGM Resorts

    Reuters
    May 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Estee Lauder and MGM Resorts, on Friday. HIGHLIGHTS * LinkedIn Corp : BMO, JP Morgan, Canaccord Genuity, others raise...

    Tags: Triumph Group Inc., Costco Wholesale Corporation, Weight, Tanger Factory Outlet Centers Incorporated, Petroleum Industry

    7. May 2, 2013 |Story| Reuters

  7. CORRECTED-Gilead profit rises 63 pct, sales of older HIV drugs dip

    Reuters
    (Corrects 3rd paragraph to show Complera sales rose 184 percent, not 10 percent; shows that sales of Stribild totaled $92.1 million, with no prior year comparison, not that they rose 184 percent) May 2 (Reuters) - Gilead Sciences Inc said on Thursday its...

    Tags: Thomson Corporation, HIV, Truvada, Earnings Forecasts, New Products

    8. May 2, 2013 |Story| Reuters

  8. U.S. RESEARCH ROUNDUP: MasterCard, Visa, Facebook, Las Vegas Sands

    Reuters
    May 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Visa and Facebook, on Thursday. HIGHLIGHTS * MasterCard Inc : Nomura cuts target price to $593 from $611; rating buy * DXP...

    Tags: Superior Energy Services Incorporated, Pinnacle Entertainment Incorporated, Viacom Inc., Weight, Micron Technology Incorporated

    9. May 2, 2013 |Story| Reuters

  9. US STOCKS SNAPSHOT-Nasdaq up 1 pct as Wall St extends advance

    Reuters
    NEW YORK, May 2 (Reuters) - U.S. stocks extended their advance on Thursday, with the Nasdaq Composite up 1 percent, led by gains in shares of Apple and Gilead Sciences. The Dow Jones industrial average rose 113.46 points or 0.77 percent, to 14,814.41,...

    Tags: European Central Bank, NASDAQ, Stock Activities, Money and Monetary Policy, Nasdaq Composite

    10. Apr 29, 2013 |Story| Reuters

  10. U.S. RESEARCH ROUNDUP: 3M, Time Warner, Walt Disney, Caterpillar

    Reuters
    April 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Time Warner, 3M Co and Caterpillar, on Monday. HIGHLIGHTS * 3M Co : JP Morgan cuts target price to $95 from $97; rating...

    Tags: MDC Partners Incorporated, Viacom Inc., Weight, Realty Income Corporation, Supervalu Inc.

    11. Jul 16, 2012 |Story| KTLA-LTV

  11. FDA Approves First Ever HIV Prevention Drug

    LOS ANGELES -- Adults who do not have HIV but are at risk of getting the disease will now be able to take a drug to reduce their chance of getting infected.
    KTLA News
    LOS ANGELES -- Adults who do not have HIV but are at risk of getting the disease will now be able to take a drug to reduce their chance of getting infected. For the first time, the U.S. Food and Drug Administration approved a drug for this use on Monday....

    Tags: University of Washington, Tenofovir (drug), Viral Diseases and Infections, Medical Research, AIDS

    12. Jul 16, 2012 |Story| Baltimore Sun

  12. FDA approves drug to prevent HIV infection

    The federal government has approved for the first time a drug that can prevent an HIV infection, a significant development for Baltimore where transmission rates for the virus remain high and growing.
    The federal government has approved for the first time a drug that can prevent an HIV infection, a significant development for Baltimore where transmission rates for the virus remain high and growing. The U.S. Food and Drug Administration approved...

    Tags: Viral Diseases and Infections, Sexually Transmitted Diseases, Hepatitis B , AIDS, Medical Procedures and Tests

 1  2 • Next >
Original site for Gilead Sciences Inc. topic gallery.